Africa Generic Pharmaceutical Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Product Type Segment
                            1.1.1.2. Drug Class Segment
                            1.1.1.3. Application Segment
                            1.1.1.4. Distribution Channel Segment
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Objectives
                        1.4.1. Objective - 1
                        1.4.2. Objective - 2
                        1.4.3. Objective - 3
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary Research
                    1.7. Information or Data Analysis
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List of Secondary Sources
                    1.11. List of Abbreviations
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Type and Product Snapshot
                    2.3. Application and Distribution Channel Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Emerging chronic diseases patients
                            3.2.1.2. Increasing number of new FDA generics approvals
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High cost of production
                    3.3. SWOT Analysis, by Factor
                    3.4. Industry Analysis- Porter’s
Chapter 4. Type Business Analysis
                    4.1. Africa Generic Pharmaceutical Market: Type Movement Analysis
                    4.2. Simple Generics
                        4.2.1. Simple Generics Market, 2018 - 2030 (USD Million)
                    4.3. Specialty Generics
                        4.3.1. Specialty Generics Market, 2018 - 2030 (USD Million)
                    4.4. Biosimilars
                        4.4.1. Biosimilars Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
                    5.1. Africa Generic Pharmaceutical Market: Application Movement Analysis
                    5.2. Central Nervous System Disorders
                        5.2.1. Central Nervous System Disorders Market, 2018 - 2030 (USD Million)
                    5.3. Respiratory Diseases
                        5.3.1. Respiratory Diseases Market, 2018 - 2030 (USD Million)
                    5.4. Hormones & Related Diseases
                        5.4.1. Hormones & Related Diseases Market, 2018 - 2030 (USD Million)
                    5.5. Gastrointestinal Diseases
                        5.5.1. Gastrointestinal Diseases Market, 2018 - 2030 (USD Million)
                    5.6. Cardiovascular Diseases
                        5.6.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
                    5.7. Infectious Diseases
                        5.7.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
                    5.8. Cancer
                        5.8.1. Cancer Market, 2018 - 2030 (USD Million)
                    5.9. Diabetes
                        5.9.1. Diabetes Market, 2018 - 2030 (USD Million)
                    5.10. Others
                        5.10.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Product Business Analysis
                    6.1. Africa Generic Pharmaceutical Market: Product Movement Analysis
                    6.2. Small Molecule
                        6.2.1. Small Molecule Market, 2018 - 2030 (USD Million)
                    6.3. Large Molecule
                        6.3.1. Large Molecule Market, 2018 - 2030 (USD Million)
Chapter 7. Route of Administration Business Analysis
                    7.1. Africa Generic Pharmaceutical Market: Route of Administration Movement Analysis
                    7.2. Oral
                        7.2.1. Oral Market, 2018 - 2030 (USD Million)
                    7.3. Injectable
                        7.3.1. Injectable Molecule Market, 2018 - 2030 (USD Million)
                    7.4. Inhalable
                        7.4.1. Inhalable Molecule Market, 2018 - 2030 (USD Million)
                    7.5. Others
                        7.5.1. Others Molecule Market, 2018 - 2030 (USD Million)
Chapter 8. Distribution Channel Business Analysis
                    8.1. Africa Generic Pharmaceutical Market: Distribution Channel Movement Analysis
                    8.2. Retail Pharmacies
                        8.2.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
                    8.3. Hospital Pharmacies
                        8.3.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
                    8.4. Others
                        8.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Africa Generic Pharmaceutical Market: Regional Business Analysis
                    9.1. Regional Market Snapshot
                    9.2. Africa
                        9.2.1. Africa Generic Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (USD Million)
                        9.2.2. Botswana
                            9.2.2.1. Botswana Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.2.2. Key Country Dynamics
                            9.2.2.3. Regulatory Framework
                            9.2.2.4. Reimbursement Scenario
                            9.2.2.5. Competitive Scenario
                        9.2.3. Namibia
                            9.2.3.1. Namibia Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.3.2. Key Country Dynamics
                            9.2.3.3. Regulatory Framework
                            9.2.3.4. Reimbursement Scenario
                            9.2.3.5. Competitive Scenario
                        9.2.4. Zimbabwe
                            9.2.4.1. Zimbabwe Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.4.2. Key Country Dynamics
                            9.2.4.3. Regulatory Framework
                            9.2.4.4. Reimbursement Scenario
                            9.2.4.5. Competitive Scenario
                        9.2.5. Zambia
                            9.2.5.1. Zambia Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.5.2. Key Country Dynamics
                            9.2.5.3. Regulatory Framework
                            9.2.5.4. Reimbursement Scenario
                            9.2.5.5. Competitive Scenario
                        9.2.6. Tanzania
                            9.2.6.1. Tanzania Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.6.2. Key Country Dynamics
                            9.2.6.3. Regulatory Framework
                            9.2.6.4. Reimbursement Scenario
                            9.2.6.5. Competitive Scenario
                        9.2.7. Rwanda
                            9.2.7.1. Rwanda Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.7.2. Key Country Dynamics
                            9.2.7.3. Regulatory Framework
                            9.2.7.4. Reimbursement Scenario
                            9.2.7.5. Competitive Scenario
                        9.2.8. Ghana
                            9.2.8.1. Ghana Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.8.2. Key Country Dynamics
                            9.2.8.3. Regulatory Framework
                            9.2.8.4. Reimbursement Scenario
                            9.2.8.5. Competitive Scenario
                        9.2.9. Nigeria
                            9.2.9.1. Nigeria Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.9.2. Key Country Dynamics
                            9.2.9.3. Regulatory Framework
                            9.2.9.4. Reimbursement Scenario
                            9.2.9.5. Competitive Scenario
                        9.2.10. South Africa
                            9.2.10.1. South Africa Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.10.2. Key Country Dynamics
                            9.2.10.3. Regulatory Framework
                            9.2.10.4. Reimbursement Scenario
                            9.2.10.5. Competitive Scenario
                        9.2.11. Angola
                            9.2.11.1. Angola Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.11.2. Key Country Dynamics
                            9.2.11.3. Regulatory Framework
                            9.2.11.4. Reimbursement Scenario
                            9.2.11.5. Competitive Scenario
                        9.2.12. Mozambique
                            9.2.12.1. Mozambique Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.12.2. Key Country Dynamics
                            9.2.12.3. Regulatory Framework
                            9.2.12.4. Reimbursement Scenario
                            9.2.12.5. Competitive Scenario
                        9.2.13. Cameroon
                            9.2.13.1. Cameroon Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.13.2. Key Country Dynamics
                            9.2.13.3. Regulatory Framework
                            9.2.13.4. Reimbursement Scenario
                            9.2.13.5. Competitive Scenario
                        9.2.14. Senegal
                            9.2.14.1. Senegal Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.14.2. Key Country Dynamics
                            9.2.14.3. Regulatory Framework
                            9.2.14.4. Reimbursement Scenario
                            9.2.14.5. Competitive Scenario
                        9.2.15. Ivory Coast
                            9.2.15.1. Ivory Coast Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.15.2. Key Country Dynamics
                            9.2.15.3. Regulatory Framework
                            9.2.15.4. Reimbursement Scenario
                            9.2.15.5. Competitive Scenario
                        9.2.16. Rest Sub-Saharan Africa
                            9.2.16.1. Rest Sub-Saharan Africa Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
                            9.2.16.2. Key Country Dynamics
                            9.2.16.3. Regulatory Framework
                            9.2.16.4. Reimbursement Scenario
                            9.2.16.5. Competitive Scenario
                    9.3. Rest of Africa and Sub-Saharan Africa
                        9.3.1. Rest of Africa and Sub-Saharan Africa Generic Pharmaceutical Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Company Categorization
                    10.2. Strategy Mapping
                    10.3. Company Market Share Analysis, 2022
                    10.4. Company Profiles/Listing
                        10.4.1. Abbott Laboratories
                            10.4.1.1. Overview
                            10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.1.3. Product Benchmarking
                            10.4.1.4. Strategic Initiatives
                        10.4.2. F. Hoffmann-La Roche Ltd
                            10.4.2.1. Overview
                            10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.2.3. Product Benchmarking
                            10.4.2.4. Strategic Initiatives
                        10.4.3. Novartis AG
                            10.4.3.1. Overview
                            10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.3.3. Product Benchmarking
                            10.4.3.4. Strategic Initiatives
                        10.4.4. Cipla South Africa
                            10.4.4.1. Overview
                            10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.4.3. Product Benchmarking
                            10.4.4.4. Strategic Initiatives
                        10.4.5. Aspen Holdings
                            10.4.5.1. Overview
                            10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.5.3. Product Benchmarking
                            10.4.5.4. Strategic Initiatives
                        10.4.6. Teva Pharmaceutical Industries Ltd.
                            10.4.6.1. Overview
                            10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.6.3. Product Benchmarking
                            10.4.6.4. Strategic Initiatives
                        10.4.7. Endo International plc
                            10.4.7.1. Overview
                            10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.7.3. Product Benchmarking
                            10.4.7.4. Strategic Initiatives
                        10.4.8. Viatris, Inc.
                            10.4.8.1. Overview
                            10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.8.3. Product Benchmarking
                            10.4.8.4. Strategic Initiatives
                        10.4.9. Sun Pharmaceutical Industries Ltd.
                            10.4.9.1. Overview
                            10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.9.3. Product Benchmarking
                            10.4.9.4. Strategic Initiatives
                        10.4.10. Lupin
                            10.4.10.1. Overview
                            10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.10.3. Product Benchmarking
                            10.4.10.4. Strategic Initiatives
                        10.4.11. AbbVie Inc.
                            10.4.11.1. Overview
                            10.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.11.3. Product Benchmarking
                            10.4.11.4. Strategic Initiatives
                        10.4.12. Aurobindo Pharma
                            10.4.12.1. Overview
                            10.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.12.3. Product Benchmarking
                            10.4.12.4. Strategic Initiatives
                        10.4.13. Sanofi
                            10.4.13.1. Overview
                            10.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.13.3. Product Benchmarking
                            10.4.13.4. Strategic Initiatives
                        10.4.14. Hikma Pharmaceuticals
                            10.4.14.1. Overview
                            10.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.14.3. Product Benchmarking
                            10.4.14.4. Strategic Initiatives
                        10.4.15. Dr. Reddy’s Laboratories Ltd.
                            10.4.15.1. Overview
                            10.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            10.4.15.3. Product Benchmarking
                            10.4.15.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 List of Secondary Sources
Table 4 List of Abbreviations
Table 5 Africa Generic Pharmaceutical Market, By Region, 2018 - 2030 (USD Million)
Table 6 Africa Generic Pharmaceutical Market, By Country, 2018 - 2030 (USD Million)
Table 7 Africa Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 8 Africa Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 9 Africa Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 10 Africa Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 11 Africa Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 Botswana Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 13 Botswana Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 14 Botswana Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 15 Botswana Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 16 Botswana Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Namibia Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 18 Namibia Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 19 Namibia Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 20 Namibia Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 21 Namibia Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Zimbabwe Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 23 Zimbabwe Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 24 Zimbabwe Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 25 Zimbabwe Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 Zimbabwe Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Zambia Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 28 Zambia Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 29 Zambia Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 30 Zambia Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 Zambia Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Tanzania Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 33 Tanzania Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 34 Tanzania Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 35 Tanzania Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 36 Tanzania Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Rwanda Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 38 Rwanda Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 39 Rwanda Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 40 Rwanda Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 41 Rwanda Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Ghana Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 43 Ghana Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 44 Ghana Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 45 Ghana Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Ghana Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Nigeria Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 48 Nigeria Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 49 Nigeria Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 50 Nigeria Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Nigeria Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 South Africa Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 53 South Africa Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 54 South Africa Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 55 South Africa Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 56 South Africa Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 Angola Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 58 Angola Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 59 Angola Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 60 Angola Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 61 Angola Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Mozambique Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 63 Mozambique Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 64 Mozambique Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 65 Mozambique Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Mozambique Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Cameroon Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 68 Cameroon Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 69 Cameroon Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 70 Cameroon Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 Cameroon Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Senegal Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 73 Senegal Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 74 Senegal Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 75 Senegal Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 Senegal Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 Ivory Coast Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 78 Ivory Coast Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 79 Ivory Coast Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 80 Ivory Coast Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 81 Ivory Coast Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 82 Rest Sub-Saharan Africa Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 83 Rest Sub-Saharan Africa Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 84 Rest Sub-Saharan Africa Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 85 Rest Sub-Saharan Africa Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Rest Sub-Saharan Africa Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 87 Rest of Africa Generic Pharmaceutical Market, By Type, 2018 - 2030 (USD Million)
Table 88 Rest of Africa Generic Pharmaceutical Market, By Application, 2018 - 2030 (USD Million)
Table 89 Rest of Africa Generic Pharmaceutical Market, By Product, 2018 - 2030 (USD Million)
Table 90 Rest of Africa Generic Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Rest of Africa Generic Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Company market share, 2022

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Africa Generic Pharmaceutical Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Africa generic pharmaceutical market: Type outlook and key takeaways
Fig. 15 Africa generic pharmaceutical market: Type movement analysis & market share 2022 & 2030
Fig. 16 Simple generics market, 2018 - 2030 (USD Million)
Fig. 17 Specialty generics market, 2018 - 2030 (USD Million)
Fig. 18 Biosimilars market, 2018 - 2030 (USD Million)
Fig. 19 Africa generic pharmaceutical market: Application outlook and key takeaways
Fig. 20 Africa generic pharmaceutical market: Application movement analysis & market share 2022 & 2030
Fig. 21 Central nervous system disorders market, 2018 - 2030 (USD Million)
Fig. 22 Respiratory diseases market, 2018 - 2030 (USD Million)
Fig. 23 Hormones & related diseases market, 2018 - 2030 (USD Million)
Fig. 24 Gastrointestinal diseases market, 2018 - 2030 (USD Million)
Fig. 25 Cardiovascular diseases market, 2018 - 2030 (USD Million)
Fig. 26 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 27 Cancer market, 2018 - 2030 (USD Million)
Fig. 28 Diabetes market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Africa generic pharmaceutical market: Product outlook and key takeaways
Fig. 31 Africa generic pharmaceutical market: Product movement analysis & market share 2022 & 2030
Fig. 32 Small molecule market, 2018 - 2030 (USD Million)
Fig. 33 Large molecule market, 2018 - 2030 (USD Million)
Fig. 34 Africa generic pharmaceutical market: Route of Administration outlook and key takeaways
Fig. 35 Africa generic pharmaceutical market: Route of Administration movement analysis & market share 2022 & 2030
Fig. 36 Oral market, 2018 - 2030 (USD Million)
Fig. 37 Injectable market, 2018 - 2030 (USD Million)
Fig. 38 Inhalable market, 2018 - 2030 (USD Million)
Fig. 39 Others market, 2018 - 2030 (USD Million)
Fig. 40 Africa generic pharmaceutical market: Distribution channel outlook and key takeaways
Fig. 41 Africa generic pharmaceutical market: Distribution channel movement analysis & market share 2022 & 2030
Fig. 42 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 43 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 44 Others market, 2018 - 2030 (USD Million)
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 Africa generic pharmaceutical market: Regional movement analysis
Fig. 47 Africa generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 48 Botswana generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 49 Namibia generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 50 Zimbabwe generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 51 Zambia generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 52 Tanzania generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 53 Rwanda generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 54 Ghana generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 55 Nigeria generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 56 South Africa generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 57 Angola generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 58 Mozambique generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 59 Cameroon generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 60 Senegal generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 61 Ivory Coast generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 62 Rest Sub-Saharan Africa generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 63 Rest of Africa and Sub-Saharan Africa generic pharmaceutical market, 2018 - 2030 (USD Million)
Fig. 64 Strategy framework